BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2910484)

  • 1. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
    Kovacs G; Frisch S
    Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases.
    Kovacs G
    Am J Pathol; 1989 Jan; 134(1):27-34. PubMed ID: 2913826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
    Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
    Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
    Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
    J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
    Lau LC; Tan PH; Chong TW; Foo KT; Yip S
    Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics.
    Beck JL; Hopman AH; Feitz WF; Schalken J; Schaafsma HE; Van de Kaa CA; Ramaekers FC; Hanselaar AG; De Wilde PC
    J Pathol; 1995 Jun; 176(2):123-35. PubMed ID: 7636622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
    Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas.
    Kenck C; Bugert P; Wilhelm M; Kovacs G
    Oncogene; 1997 Mar; 14(9):1093-8. PubMed ID: 9070658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome abnormalities in tumor cells from patients with sporadic Wilms' tumor.
    Kondo K; Chilcote RR; Maurer HS; Rowley JD
    Cancer Res; 1984 Nov; 44(11):5376-81. PubMed ID: 6091875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
    Wilhelm M; Bugert P; Kenck C; Staehler G; Kovacs G
    Cancer Res; 1995 Nov; 55(22):5383-5. PubMed ID: 7585605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific chromosome aberration in human renal cell carcinoma.
    Kovacs G; Szücs S; De Riese W; Baumgärtel H
    Int J Cancer; 1987 Aug; 40(2):171-8. PubMed ID: 3610386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.
    Shridhar V; Wang L; Rosati R; Paradee W; Shridhar R; Mullins C; Sakr W; Grignon D; Miller OJ; Sun QC; Petros J; Smith DI
    Oncogene; 1997 Mar; 14(11):1269-77. PubMed ID: 9178887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.